What Parnell Living Science does

Parnell Living Science is a fully integrated veterinary pharmaceutical company operating across livestock and companion-animal segments in approximately 14 countries, with its U.S. headquarters in Overland Park, Kansas and regional offices in Australia and New Zealand. The company develops, manufactures, and markets FDA- and EMA-accredited sterile veterinary pharmaceuticals including reproductive hormones (GONAbreed, estroPLAN), bovine respiratory disease treatments (RESPIRmycin, nixiFLOR), and a companion-animal anesthesia, sedation, and euthanasia portfolio (PropofolVet Multidose, Dexmedetomidine, CONTRASED, Isoflurane, Pentobarbital Sodium/Phenytoin). In November 2025 it acquired Noble Pharma LLC, adding FDA- and DEA-accredited U.S. manufacturing capacity and enabling contract manufacturing services.

The company's go-to-market is a hybrid sales-led motion combining direct engagement with herd-health veterinarians and livestock producers with a deep distributor network — 13 livestock partners (MWI, Animal Health International, Leedstone, Vedco, etc.) and 5 pet care partners (Covetrus, Patterson Veterinary, Amatheon, First Veterinary Supply, Penn Veterinary Supply). Revenue is generated primarily through one-time pharmaceutical product sales, supplemented by subscription/recurring digital services through the mySYNCH cloud-based herd management platform (which tracks 1M+ milking cows and 2.2M+ animals), a $299/user RACE-approved CE certificate program gated to qualifying product purchases, and new contract manufacturing revenue from the Wisconsin facility.

Parnell's stated strategy is a 'Beyond the Bottle' model bundling pharmaceuticals with the mySYNCH digital platform, on-farm technical services, compliance training, and reproductive reviews. The company has prioritized first-mover FDA generic approvals (nixiFLOR, PropofolVet Multidose) and has executed an active 2025–2026 expansion through acquisition, product launches, and new financing. Reported as publicly traded on otcpink:PARNF with leadership including CEO Wes Dittmer and CFO/COO Brad McCarthy, though the provided financial disclosures contain apparent unit errors and require independent verification.

Name

Parnell Living Science

Legal name

Parnell Technologies Pty. Ltd.

Website

https://parnell.com

Company type

Private

Founded year

1970

Operating status

Operating

Headcount range

101–250 employees

Ownership category

akta.pro rank

Product category

Veterinary Pharmaceuticals

NAICS

Veterinary Services (541940), Support Activities for Animal Production (1152)

SIC

Agricultural Prod-Livestock & Animal Specialties (200), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Veterinary Pharmacy, Vaccine & Biologics Services (AFAEANAK)

akta.pro secondary industries

Pain Management, Anesthesia & Critical Care Drugs (HLAMAEAF), Livestock & Farm Animal Veterinary Services (AFAEANAB), Food Animal (Bovine/Dairy/Beef) Veterinary Services (HLAMABAA)

Keywords

• Veterinary pharmaceuticals
• Animal health products
• Livestock reproductive solutions
• Companion animal anesthesia
• Herd management software

Headquarters

HQ city

Overland Park

HQ country

United States

HQ region

North America

Offices5 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Product Sales: Parnell generates revenue through the sale of veterinary pharmaceutical products including livestock products (GONAbreed, estroPLAN, RESPIRmycin, nixiFLOR) and pet care products (PropofolVet Multidose, Dexmedetomidine, CONTRASED, Isoflurane, Pentobarbital Sodium/Phenytoin). Products are sold through distributors and directly to veterinarians.
2. Education and Certificate Programs: Revenue generated through the Foundations of Anesthesia & Sedation Veterinary Certificate program, valued at $299/user, offered exclusively to clinics purchasing qualifying Parnell manufactured products. This creates a demand generation mechanism while generating direct revenue.
3. Contract Manufacturing Services: Following the acquisition of Noble Pharma LLC, Parnell offers contract manufacturing capabilities from its FDA- and DEA-accredited facility in Menomonie, Wisconsin. The facility specializes in various pharmaceutical forms including suspensions, liquids, tablets, boluses, powders, gels, pastes, creams, and ointments.
4. Digital Technology Services (mySYNCH): The mySYNCH platform and services generate revenue through a combination of software access, data analytics services, on-farm support, compliance training, and reproductive reviews for dairy operations.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

Parnell is a fully integrated veterinary pharmaceutical company that develops, manufactures, and markets FDA- and EMA-approved animal health products for livestock (dairy and beef reproduction and respiratory health) and companion animals (anesthesia, sedation, pain management, euthanasia). The company complements its drug portfolio with the mySYNCH digital herd-management platform, contract manufacturing services, and veterinary continuing-education programs, distributing through major animal-health distributors and herd-health veterinarians in 14 countries.

Differentiator

Problem solved

Functional benefit

Brands

• mySYNCH: Comprehensive suite of digital technology, services, and insights for dairy herd reproductive management, combining advanced analytics, on-farm support, and compliance training.
• nixiFLOR
• GONAbreed
• estroPLAN
• RESPIRmycin
• PropofolVet Multidose
• Dexmedetomidine Hydrochloride Injection
• CONTRASED
• Isoflurane Inhalation Anesthetic
• Pentobarbital Sodium and Phenytoin Sodium Euthanasia Solution

Products and services

• GONAbreed Gonadorelin acetate veterinary product for treatment of cystic ovaries and use in cattle synchronization protocols to optimize timed artificial insemination. Used by dairy and beef producers and their veterinarians.
• estroPLAN Cloprostenol sodium prostaglandin solution used to induce regression of the corpus luteum and manipulate the estrous cycle in cattle. Used by herd-health veterinarians managing dairy and beef reproductive programs.
• RESPIRmycin Tulathromycin injection indicated for treatment of bovine and swine respiratory disease, used in beef cattle, dairy cattle, calves, and swine. Sold to livestock producers and veterinarians.
• nixiFLOR First FDA-approved generic florfenicol + flunixin meglumine combination administered as a single-dose subcutaneous injection for treatment of bovine respiratory disease (BRD) in beef and non-lactating dairy cattle. Targeted at livestock producers and herd-health veterinarians needing a cost-effective BRD therapy.
• PropofolVet Multidose First generic propofol injectable emulsion for dogs, used for induction and maintenance of general anesthesia. Sold to companion-animal veterinary practices.
• Dexmedetomidine Hydrochloride Injection Sedative and analgesic injection for dogs and cats used during clinical examinations, procedures, and preanesthesia. Sold to companion-animal veterinary practices.
• CONTRASED Atipamezole hydrochloride injection used for rapid reversal of dexmedetomidine effects in dogs. Sold to companion-animal veterinary practices to support sedation reversal protocols.
• Isoflurane Inhalation Anesthetic Inhalant anesthetic for induction and maintenance of general anesthesia in horses and dogs. Sold to veterinary practices for use in companion-animal and equine procedures.
• Pentobarbital Sodium and Phenytoin Sodium Euthanasia Solution Euthanasia solution for dogs delivering humane, painless, and rapid euthanasia, supplied in 100 mL multi-dose vials. Sold to companion-animal veterinary practices for end-of-life care.
• mySYNCH Platform and Services Cloud-based web application and service bundle that transforms herd-management data into insights for dairy reproductive management, combining advanced analytics, on-farm support, compliance training, and reproductive reviews. Tracks over 1 million milking cows and serves a community database of over 2.2 million animals. Used by dairy operations.
• Foundations of Anesthesia & Sedation Veterinary Certificate RACE-approved continuing-education certificate program delivering 10 CE hours on anesthesia and sedation, created with veterinary professionals and exclusive to clinics purchasing qualifying Parnell-manufactured products. Priced at $299 per user, with tiered access based on product purchases. Sold to companion-animal veterinary clinics.
• Contract Manufacturing Services FDA- and DEA-accredited contract manufacturing services delivered from the Menomonie, Wisconsin facility acquired through Noble Pharma LLC, covering suspensions, liquids, tablets, boluses, powders, gels, pastes, creams, and ointments. Offered to pharmaceutical companies seeking third-party manufacturing capacity.

Quantifiable outcome

• nixiFLOR provides visible improvement in as little as 6 hours for BRD treatment
• +2 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Two partnerships are on record, tiered core.

• Noble Pharma LLCcoreOEM/ Whitelabel/ Licensing Partner · 26 November 2025Parnell acquired Noble Pharma LLC, a U.S.-based FDA- and DEA-accredited pharmaceutical manufacturer located in Menomonie, Wisconsin. The acquisition strengthens Parnell's U.S. manufacturing footprint with capabilities spanning suspensions, liquids, tablets, boluses, powders, gels, pastes, creams, and ointments. This positions Parnell for continued expansion across the U.S. market and enables increased production and innovation.
• IGNITEcoreStrategic or Co-development PartnerParnell partnered with IGNITE, a veterinary learning company, to develop the Foundations of Anesthesia & Sedation Veterinary Certificate program. The program was created by veterinary professionals in anesthesia, critical care, neurology, and pharmacology and provides 10 RACE-approved CE hours exclusively to clinics purchasing qualifying Parnell manufactured products.

Scale indicators5 records

Recent moves7 records

Expansion highlights7 records

Direct peers

• Zoetis: World's largest pure-play animal health company; directly competes across livestock reproductive/respiratory pharmaceuticals and companion-animal anesthesia/sedation, making it Parnell's most direct large-cap peer.
• Elanco Animal Health: Global animal health pharmaceutical company with overlapping livestock (reproductive, BRD) and companion-animal portfolios; competes head-to-head with Parnell's branded and generic product lines.
• Merck Animal Health: Animal health division of Merck offering vaccines, pharmaceuticals, and digital tools for livestock and pets; competes with Parnell's livestock reproductive/respiratory portfolio and pet anesthesia/sedation range.
• Virbac: Independent global animal health company with companion-animal focus including anesthesia/sedation; a close functional peer to Parnell's pet-care anesthesia portfolio (Dexmedetomidine, propofol, isoflurane).
• Dechra Pharmaceuticals: Specialty veterinary pharma focused on companion-animal endocrinology, anesthesia, and critical care; directly comparable to Parnell's pet-care segment across sedation, euthanasia, and pain products.
• Phibro Animal Health: Animal health and nutrition company with strong livestock pharmaceutical and medicated feed additive portfolio; comparable to Parnell's livestock product range targeting dairy and beef producers.
• Vetoquinol: French veterinary pharma with companion-animal and livestock portfolios including reproductive and respiratory products; competes with Parnell in specialty vet pharmaceutical niches across multiple geographies.

Broad incumbents

• Boehringer Ingelheim Animal Health: Top-3 global animal health franchise offering vaccines, parasiticides, and pharmaceuticals across species; broader portfolio but comparable in livestock reproductive/respiratory therapeutics where Parnell competes.
• Ceva Santé Animale: Large privately-held animal health company spanning pharmaceuticals, vaccines, and digital monitoring for livestock and pets; competes with Parnell across species but at greater scale and with broader product breadth.

Emerging players

• Valley Ag Software (DairyComp / PULSE): Dairy herd management software provider with longstanding on-farm installed base; directly competes with mySYNCH for dairy operation data analytics and reproductive program management.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/parnell

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries1 record

Funding overview

Funding rounds4 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Parnell Living Science